| 1 |
Malkan UY, Haznedaroglu IC, Gu Y. Antineoplastic Effects of Ankaferd Hemostat. BioMed Research International 2022;2022:1-11. [DOI: 10.1155/2022/2665903] [Reference Citation Analysis]
|
| 2 |
Sarı H, Çelik S, Çağlar F, Aktaş S, Bozkurt O, Yörükoğlu K, Çelebi İ, Mungan MU. A candidate antineoplastic herbal agent for bladder cancer: Ankaferd Blood Stopper. Int J Clin Pract 2021;75:e14789. [PMID: 34480836 DOI: 10.1111/ijcp.14789] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Zeki ÖC, Nenni M, Çelebier M, Öncül S, Ercan A, Süslü İ, Haznedaroğlu İC. Antitumor activity of Ankaferd Blood Stopper® on MCF-7 breast cancer: A proteomic approach to ascertain the mechanism of the action. Journal of Herbal Medicine 2021;28:100449. [DOI: 10.1016/j.hermed.2021.100449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 4 |
Koşmaz K, Durhan A, Süleyman M, Ünal Y, Bostancı MT, Yiğit Haskaraca T, Ersak C, Şener M, Kuşabbi İA, Eser EP, Hücümenoğlu S. The effect of Ankaferd blood stopper on liver damage in experimental obstructive jaundice. Turk J Med Sci 2021;51:1472-80. [PMID: 32979898 DOI: 10.3906/sag-2007-298] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Burdurlu MÇ, Cabbar F, Dagasan VÇ, Işıksaçan NS, Olgaç V. The preventive effect of medicinal herbal extract and gelatin sponge on alveolar osteitis: An in vivo micro-computed tomography and immunohistochemical analysis in rats. Arch Oral Biol 2021;122:105002. [PMID: 33316659 DOI: 10.1016/j.archoralbio.2020.105002] [Reference Citation Analysis]
|
| 6 |
Çiftçiler R, Haznedaroglu İC. Ankaferd hemostat: from molecules to medicine. Turk J Med Sci 2020;50:1739-50. [PMID: 32283900 DOI: 10.3906/sag-1908-161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Haznedaroğlu IC, Çelebier M. Antiinfective and wound-healing pleiotropic actions of Ankaferd hemostat. Turk J Med Sci 2020;50:1434-5. [PMID: 32305048 DOI: 10.3906/sag-2004-94] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 8 |
Beyazit F, Beyazit Y, Tanoglu A, Haznedaroglu IC. Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content. Med Hypotheses 2020;143:110150. [PMID: 32763660 DOI: 10.1016/j.mehy.2020.110150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Falsaperla R, Lombardo F, Filosco F, Romano C, Saporito MAN, Puglisi F, Piro E, Ruggieri M, Pavone P. Oxidative Stress in Preterm Infants: Overview of Current Evidence and Future Prospects. Pharmaceuticals (Basel) 2020;13:E145. [PMID: 32645921 DOI: 10.3390/ph13070145] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 10 |
Ciftciler R, Ciftciler AE, Malkan UY, Haznedaroglu IC. Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper). SAGE Open Med 2020;8:2050312120907811. [PMID: 32110403 DOI: 10.1177/2050312120907811] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Nisari M, Ülger H, Torun Y, Özdemir MA, Hamurcu Z. The Effect Of Ankaferd Blood Stopper As A Drug On Human Umbilical Vein Endothelial Cell Culture (Huvec). Bozok Tıp Dergisi 2019. [DOI: 10.16919/bozoktip.469448] [Reference Citation Analysis]
|
| 12 |
Akbulut A, Gursoy K, Yumusak N, Koca G, Korkmaz M. Deneysel sıçan modelinde iskemiye bağlı deri flep nekrozunda hemostatik ajan kullanım. Turkish Journal of Clinics and Laboratory 2019;10:388-395. [DOI: 10.18663/tjcl.589447] [Reference Citation Analysis]
|
| 13 |
Ekici U, Ferhatoğlu MF, Çitgez B, Uludağ M. Effects of the Folk Medicinal Plant Extract Ankaferd BloodStopper on the Healing of Colon Anastomosis: An Experimental Study in a Rat Model. Sisli Etfal Hastan Tip Bul 2019;53:154-9. [PMID: 32377075 DOI: 10.14744/SEMB.2019.98965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 14 |
Koçak E, Çelebier M, Haznedaroglu IC, Altınöz S. Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach. Biomed Res Int 2019;2019:5268031. [PMID: 31240215 DOI: 10.1155/2019/5268031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 15 |
Büyük B, Beyazıt F. The efficacy of Ankaferd Blood Stopper® in an experimental Asherman syndrome model created in rats. Turk J Obstet Gynecol 2019;16:7-14. [PMID: 31019834 DOI: 10.4274/tjod.galenos.2018.21298] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Erkose Genc G, Sahinkaya O, Demir C, Kisa O, Satana D. In Vitro Antifungal Activity of a Medicinal Plant Extract Mixture Against Candida Species Isolated from Patients with Oral Stomatitis. Iran Red Crescent Med J 2019;In Press. [DOI: 10.5812/ircmj.87251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 17 |
Beyazit F, Buyuk B. An immunohistochemistry and histopathological study of ankaferd blood stopper in a rat model of cervical inflammation. Rev Assoc Med Bras (1992) 2019;65:183-90. [PMID: 30892442 DOI: 10.1590/1806-9282.65.2.183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 18 |
Çiftçiler R, Koluman A, Haznedaroğlu İC, Akar N. Effects of Ankaferd Hemostat on Helicobacter pylori strains and antibiotic resistance. Turk J Med Sci 2019;49:347-55. [PMID: 30761849 DOI: 10.3906/sag-1807-206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Buyuktiryaki M, Tayman C, Koyuncu I, Cakir U, Taskin Turkmenoglu T, Cakir E, Okur N. Therapeutic and preventative effects of ankaferd blood stopper in an experimental necrotizing enterocolitis model. Biomed Pharmacother 2019;110:105-10. [PMID: 30465999 DOI: 10.1016/j.biopha.2018.11.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 20 |
Çiftçiler R, Haznedaroğlu İC. On Being a “Physician Patient” with His Own Experimental Therapeutic Drug. Turk J Haematol 2018;35:302-3. [PMID: 30040068 DOI: 10.4274/tjh.2018.0254] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 21 |
Safarpoor M, Ghaedi M, Asfaram A, Yousefi-nejad M, Javadian H, Zare Khafri H, Bagherinasab M. Ultrasound-assisted extraction of antimicrobial compounds from Thymus daenensis and Silybum marianum: Antimicrobial activity with and without the presence of natural silver nanoparticles. Ultrasonics Sonochemistry 2018;42:76-83. [DOI: 10.1016/j.ultsonch.2017.11.001] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 22 |
Kuru S, Kismet K, Bag YM, Barlas AM, Senes M, Durak M, Yumusak N, Urhan MK, Cavusoglu T, Pekcici R. Does the application of Ankaferd Blood Stopper rectally have positive effects on the healing of colorectal anastomosis and prevention of anastomotic leakage? An experimental study. Biomedicine & Pharmacotherapy 2017;96:968-73. [DOI: 10.1016/j.biopha.2017.11.140] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 23 |
Koç O, Acar K, Özbek O, Güler İ, Sarıtaş K, Erdem TB, Solak Y, Toy H, Küçükapan A, Özbek S, Gaipov A, Haznedaroğlu İC. Splenic artery embolization with Ankaferd blood stopper in a sheep model. Diagn Interv Radiol 2016;22:354-7. [PMID: 27306661 DOI: 10.5152/dir.2015.15382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 24 |
Turk S, Malkan UY, Ghasemi M, Hocaoglu H, Mutlu D, Gunes G, Aksu S, Haznedaroglu IC. Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines. SAGE Open Med 2017;5:2050312116689519. [PMID: 28293423 DOI: 10.1177/2050312116689519] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 25 |
Huri E, Dogantekin E, Hayran M, Malkan UY, Ergun M, Firat A, Beyazit Y, Ustun H, Kekilli M, Dadali M, Astarci M, Haznedaroglu IC. Ultrastructural analyses of the novel chimeric hemostatic agent generated via nanotechnology, ABS nanohemostat, at the renal tissue level. Springerplus 2016;5:1931. [PMID: 27917335 DOI: 10.1186/s40064-016-3625-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 26 |
Koluman A, Akar N, Malkan UY, Haznedaroglu IC. Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids. Biomed Res Int 2016;2016:8957820. [PMID: 26925418 DOI: 10.1155/2016/8957820] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 27 |
Ghaedi M, Naghiha R, Jannesar R, dehghanian N, Mirtamizdoust B, pezeshkpour V. Antibacterial and antifungal activity of flower extracts of Urtica dioica, Chamaemelum nobile and Salvia officinalis: Effects of Zn[OH]2 nanoparticles and Hp-2-minh on their property. Journal of Industrial and Engineering Chemistry 2015;32:353-9. [DOI: 10.1016/j.jiec.2015.09.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 28 |
Karaman K, Aydin İ, Akbayram S, Garipardiç M. The Use of Ankaferd Blood Stopper in a Child With Glanzmann Thrombasthenia With Gingival Bleeding. J Pediatr Hematol Oncol 2015;37:571-2. [PMID: 26207779 DOI: 10.1097/MPH.0000000000000403] [Reference Citation Analysis]
|
| 29 |
Koluman A, Akar N, Haznedaroğlu İC. Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases. Turk J Haematol 2017;34:93-8. [PMID: 26377624 DOI: 10.4274/tjh.2015.0073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 30 |
Abacıoğlu S, Aydın K, Büyükcam F, Kaya U, Işık B, Karakılıç ME. Comparison of the Efficiencies of Buffers Containing Ankaferd and Chitosan on Hemostasis in an Experimental Rat Model with Femoral Artery Bleeding. Turk J Haematol 2016;33:48-52. [PMID: 25913214 DOI: 10.4274/tjh.2014.0029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 31 |
Ozturk O, Koklu S, Basar O, Haznedaroglu IC. Severe radiation esophagitis successfully treated with Ankaferd hemostat. Gastrointest Endosc 2015;81:1048-9. [PMID: 25805479 DOI: 10.1016/j.gie.2014.10.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 32 |
Foster L. Bioadhesives as Surgical Sealants: A Review. Bioadhesion and Biomimetics 2015. [DOI: 10.1201/b18095-14] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 33 |
Sarıkaş NG, Korkmaz T, Kahramansoy N, Kılıçgün A, Boran Ç, Boztaş G. The effects of ankaferd blood stopper on the recovery process in an experimental oesophageal perforation model. Balkan Med J 2015;32:96-100. [PMID: 25759779 DOI: 10.5152/balkanmedj.2015.15459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 34 |
Akar N, Ardçoğlu Y, Öktem Z, Erduran N, Haznedaroglu IC. High iron content of Ankaferd hemostat as a clue for its hemostatic action of red blood cell origin. Blood Coagul Fibrinolysis 2015;26:233-4. [PMID: 25629421 DOI: 10.1097/MBC.0000000000000223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 35 |
Mumcuoglu M, Akin DF, Ezer U, Akar N. Ankaferd Blood Stopper induces apoptosis and regulates PAR1 and EPCR expression in human leukemia cells. Egyptian Journal of Medical Human Genetics 2015;16:19-27. [DOI: 10.1016/j.ejmhg.2014.10.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 36 |
Uzun O, Erkan L, Haznedaroglu IC. Effective Management of Hemoptysis Via Endobronchial Application of Ankaferd Hemostat. Archivos de Bronconeumología (English Edition) 2014;50:407-409. [DOI: 10.1016/j.arbr.2014.08.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 37 |
Beyazit Y, Onder FO, Torun S, Tas A, Purnak T, Tenlik I, Turhan N. Topical application of ankaferd hemostat in a patient with gastroduodenal amyloidosis complicated with gastrointestinal bleeding. Blood Coagul Fibrinolysis 2013;24:762-5. [PMID: 23751610 DOI: 10.1097/MBC.0b013e328362d996] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 38 |
Uzun O, Erkan L, Haznedaroglu IC. Effective management of hemoptysis via endobronchial application of Ankaferd hemostat. Arch Bronconeumol 2014;50:407-9. [PMID: 24491888 DOI: 10.1016/j.arbres.2013.12.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 39 |
Beyazit Y, Huri E, Purnak T, Guler MO, Haznedaroglu IC. Next generation nanomedicine in the genesis of "Ankaferd blood stopper nanohemostat": a novel chimeric topical hemostatic agent for clinical hemorrhages. Clin Appl Thromb Hemost 2014;20:456-7. [PMID: 24363214 DOI: 10.1177/1076029613507336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 40 |
Purnak T, Beyazit Y, Haznedaroglu IC. Topical Ankaferd hemostat for the management of clinical bleeding plus hemorrhagic diathesis. Gastrointestinal Intervention 2013;2:127. [DOI: 10.1016/j.gii.2013.09.001] [Reference Citation Analysis]
|
| 41 |
Sogut O, Erdogan MO, Kose R, Boleken ME, Kaya H, Gokdemir MT, Ozgonul A, Iynen I, Albayrak L, Dokuzoglu MA. Hemostatic Efficacy of a Traditional Medicinal Plant Extract (Ankaferd Blood Stopper) in Bleeding Control. Clin Appl Thromb Hemost 2015;21:348-53. [DOI: 10.1177/1076029613504129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 42 |
Cancan G, Teksoz S, Aytac E, Arikan AE, Erman H, Uzun H, Ozden F, Aydin O, Ozcan M. Effects of Ankaferd on Anastomotic Healing of Colon. Journal of Investigative Surgery 2013;27:1-6. [DOI: 10.3109/08941939.2013.826308] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Simşek HO, Tüzüm MŞ, Baykul T, Gürer IE, Başsorgun Cİ. Experimental investigation of the effects of a blood stopper agent (ankaferd blood stopper) on bone surfaces. Turk J Haematol 2013;30:177-83. [PMID: 24385782 DOI: 10.4274/Tjh.2012.0092] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 44 |
Huri E, Beyazit Y, Mammadov R, Toksoz S, Tekinay AB, Guler MO, Ustun H, Kekilli M, Dadali M, Celik T, Astarci M, Haznedaroglu IC. Generation of Chimeric "ABS Nanohemostat" Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model. Int J Biomater 2013;2013:949460. [PMID: 23509463 DOI: 10.1155/2013/949460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 45 |
Aruldass CA, Marimuthu MM, Ramanathan S, Mansor SM, Murugaiyah V. Effects of Mesua ferrea leaf and fruit extracts on growth and morphology of Staphylococcus aureus. Microsc Microanal 2013;19:254-60. [PMID: 23332129 DOI: 10.1017/S1431927612013785] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 46 |
Ozbek O, Acar K, Koc O, Saritas K, Toy H, Solak Y, Ozbek S, Kucukapan A, Guler I, Gaipov A, Turk S, Haznedaroglu IC. Short-Term Effects of Ankaferd Hemostat for Renal Artery Embolization: An Experimental Study. Cardiovasc Intervent Radiol 2013;36:498-504. [DOI: 10.1007/s00270-012-0419-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
